Preclinical data illustrated that SMOis failed to reverse pulmonary fibrosis, kidney fibrosis, and MF, whereas the direct inhibition of the GLI protein by GANT61 abated fibrosis in these tissues [84,125,155]. Here, GLI1 is linked to pulmonary fibrosis.